Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma

被引:0
作者
Zhi Chen
Zuan Li
Chunlin Li
Bingcai Li
Haojian Wang
Deyong Nong
Ximing Li
Guihai Huang
Junhao Lin
Wei Li
机构
[1] The People’s Hospital of Guangxi Zhuang Autonomous Region,Department of Urology
[2] Guangxi Academy Of Medical Sciences,undefined
来源
BMC Cancer | / 22卷
关键词
Renal cell carcinoma; Speckle-type POZ protein; In vitro proliferation; Migration; Invasion; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 357 条
  • [1] Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34
  • [2] Miller KD(2018)Epidemiology of renal cancer in developing countries: Review of the literature Can Urol Assoc J 12 E154-E162
  • [3] Jemal A(2017)Global Burden of Urologic Cancers, 1990–2013 Eur Urol 71 437-446
  • [4] Medina-Rico M(2018)WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies World J Urol 36 1913-1926
  • [5] Ramos HL(2018)Epidemiology and screening for renal cancer World J Urol 36 1341-1353
  • [6] Lobo M(2020)Research progress on advanced renal cell carcinoma J Int Med Res 48 300060520924265-5441
  • [7] Romo J(2022)Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma Curr Oncol 29 5426-110
  • [8] Prada JG(2019)Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions Eur Urol 75 100-351
  • [9] Dy GW(2016)Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma Eur Urol 69 345-336
  • [10] Gore JL(2012)Renal cell carcinoma: resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins Med Hypotheses 78 330-26